Evidence map›Paper›PMID 25879519›Full record

ArticleBMC veterinary research2015

Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses.

Leandro Maia, Fernanda da Cruz Landim-Alvarenga, Marilda Onghero Taffarel, Carolina Nogueira de Moraes, Gisele Fabrino Machado, Guilherme Dias Melo, Rogério Martins Amorim

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Leandro MaiaDepartment of Animal Reproduction, São Paulo State University, District of Rubião Júnior, n/n, CEP: 18618970, Botucatu, São Paulo, Brazil. leandromvet@hotmail.com.
Fernanda da Cruz Landim-AlvarengaDepartment of Animal Reproduction, São Paulo State University, District of Rubião Júnior, n/n, CEP: 18618970, Botucatu, São Paulo, Brazil. fernanda@fmvz.unesp.br.
Marilda Onghero TaffarelDepartment of Veterinary Medicine, Maringá State University, Av. Colombo, 5.790, CEP: 87020-900, Maringá, Paraná, Brazil. mtafarel@yahoo.com.br.
Carolina Nogueira de MoraesDepartment of Animal Reproduction, São Paulo State University, District of Rubião Júnior, n/n, CEP: 18618970, Botucatu, São Paulo, Brazil. carolnmoraes@hotmail.com.
Gisele Fabrino MachadoDepartment of Clinic, Surgery and Animal Reproduction, São Paulo State University, Clóvis Pestano, 793, CEP: 16050-680, Araçatuba, São Paulo, Brazil. giselem@fmva.unesp.br.
Guilherme Dias MeloDepartment of Clinic, Surgery and Animal Reproduction, São Paulo State University, Clóvis Pestano, 793, CEP: 16050-680, Araçatuba, São Paulo, Brazil. di.melo@uol.com.br.
Rogério Martins AmorimDepartment of Veterinary Clinics, São Paulo State University, District of Rubião Júnior, n/n, CEP: 18618970, Botucatu, São Paulo, Brazil. rmamorim@fmvz.unesp.br.
Universidade Estadual Paulista (Unesp) · BRUniversidade Estadual de Maringá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have demonstrated numerous biological properties of mesenchymal stem cells and their potential application in treating complex diseases or injuries to tissues that have difficulty regenerating, such as those affecting the central and peripheral nervous system. Thus, therapies that use mesenchymal stem cells are promising because of their high capacity for self-regeneration, their low immunogenicity, and their paracrine, anti-inflammatory, immunomodulatory, anti-apoptotic and neuroprotective effects. In this context, the purpose of this study was to evaluate the feasibility and safety of intrathecal transplantation of bone marrow-derived mesenchymal stem cells in horses, for future application in the treatment of neurological diseases.

resultsDuring the neurological evaluations, no clinical signs were observed that were related to brain and/or spinal cord injury of the animals from the control group or the treated group. The hematological and cerebrospinal fluid results from day 1 and day 6 showed no significant differences (P > 0.05) between the treated group and the control group. Additionally, analysis of the expression of matrix metalloproteinase (MMP) -2 and -9 in the cerebrospinal fluid revealed only the presence of pro-MMP-2 (latent), with no significant difference (P > 0.05) between the studied groups.

conclusionsThe results of the present study support the hypothesis of the feasibility and safety of intrathecal transplantation of autologous bone marrow-derived mesenchymal stem cells, indicating that it is a promising pathway for cell delivery for the treatment of neurological disorders in horses.

Indexed as

AnimalsBone Marrow TransplantationFeasibility StudiesFemaleHorse DiseasesHorsesInjections, SpinalMaleMesenchymal Stem Cell TransplantationNervous System Diseases

Identifiers

PMID25879519
PMCPMC4369105
OpenAlexW2015683628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.